Ensysce Biosciences's total assets for Q1 2025 were $4.61M, a decrease of -17.60% from the previous quarter. ENSC total liabilities were $130.18K for the fiscal quarter, a -94.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.